Neuroleptic-induced catatonia: neuroleptic malignant syndrome?
1. The authors describe a case report of catatonia syndrome after administration of depot neuroleptics. 2. Differential diagnosis was made between neuroleptic malignant syndrome or catatonic syndrome complicated by infection. The signs and symptoms observed throughout the patient's course are detailed. 3. A critical review is made of bibliography on the topic, with emphasis on the lack of clear clinical description and poor conceptual definition.
de Leon
J
J
Hospital Ramon y Cajal, Department of Psychiatry, Madrid, Spain.
Saiz-Ruiz
J
J
Alonso-Abolafia
A
A
Pico-Soler
E
E
Munoz-Ruata
J
J
de la Serna
I
I
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001712:Biperiden / Q000627:therapeutic use*; D002389:Catatonia / Q000175:diagnosis*; D003692:Delayed-Action Preparations; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis* / Q000188:drug therapy; D010640:Phenothiazines; D010880:Piperidines / Q000627:therapeutic use*; D012557:Schizoid Personality Disorder / Q000188:drug therapy; D013577:Syndrome; D013843:Thiazines / Q000009:adverse effects* / Q000627:therapeutic use
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D010640:Phenothiazines; D010880:Piperidines; D013843:Thiazines; D001712:Biperiden